175 related articles for article (PubMed ID: 27241692)
1. Coumarin carboxylic acids as monocarboxylate transporter 1 inhibitors: In vitro and in vivo studies as potential anticancer agents.
Gurrapu S; Jonnalagadda SK; Alam MA; Ronayne CT; Nelson GL; Solano LN; Lueth EA; Drewes LR; Mereddy VR
Bioorg Med Chem Lett; 2016 Jul; 26(14):3282-3286. PubMed ID: 27241692
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationships of pteridine dione and trione monocarboxylate transporter 1 inhibitors.
Wang H; Yang C; Doherty JR; Roush WR; Cleveland JL; Bannister TD
J Med Chem; 2014 Sep; 57(17):7317-24. PubMed ID: 25068893
[TBL] [Abstract][Full Text] [Related]
3. In Vitro and In Vivo Efficacy of the Monocarboxylate Transporter 1 Inhibitor AR-C155858 in the Murine 4T1 Breast Cancer Tumor Model.
Guan X; Bryniarski MA; Morris ME
AAPS J; 2018 Nov; 21(1):3. PubMed ID: 30397860
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anticancer activity of new coumarin-3-carboxylic acid derivatives as potential lactatetransportinhibitors.
Ji H; Tan Y; Gan N; Zhang J; Li S; Zheng X; Wang Z; Yi W
Bioorg Med Chem; 2021 Jan; 29():115870. PubMed ID: 33221062
[TBL] [Abstract][Full Text] [Related]
5. Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer.
Polański R; Hodgkinson CL; Fusi A; Nonaka D; Priest L; Kelly P; Trapani F; Bishop PW; White A; Critchlow SE; Smith PD; Blackhall F; Dive C; Morrow CJ
Clin Cancer Res; 2014 Feb; 20(4):926-937. PubMed ID: 24277449
[TBL] [Abstract][Full Text] [Related]
6. MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4.
Hong CS; Graham NA; Gu W; Espindola Camacho C; Mah V; Maresh EL; Alavi M; Bagryanova L; Krotee PAL; Gardner BK; Behbahan IS; Horvath S; Chia D; Mellinghoff IK; Hurvitz SA; Dubinett SM; Critchlow SE; Kurdistani SK; Goodglick L; Braas D; Graeber TG; Christofk HR
Cell Rep; 2016 Feb; 14(7):1590-1601. PubMed ID: 26876179
[TBL] [Abstract][Full Text] [Related]
7. Development of Novel Silyl Cyanocinnamic Acid Derivatives as Metabolic Plasticity Inhibitors for Cancer Treatment.
Nelson GL; Ronayne CT; Solano LN; Jonnalagadda SK; Jonnalagadda S; Rumbley J; Holy J; Rose-Hellekant T; Drewes LR; Mereddy VR
Sci Rep; 2019 Dec; 9(1):18266. PubMed ID: 31797891
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of N, N-dialkylcarboxy coumarin-NO donor conjugates as potential anticancer agents.
Nelson GL; Ronayne CT; Solano LN; Jonnalagadda SK; Jonnalagadda S; Schumacher TJ; Gardner ZS; Palle H; Mani C; Rumbley J; Mereddy VR
Bioorg Med Chem Lett; 2021 Nov; 52():128411. PubMed ID: 34626786
[TBL] [Abstract][Full Text] [Related]
9. In Vitro and In Vivo Efficacy of AZD3965 and Alpha-Cyano-4-Hydroxycinnamic Acid in the Murine 4T1 Breast Tumor Model.
Guan X; Morris ME
AAPS J; 2020 Jun; 22(4):84. PubMed ID: 32529599
[TBL] [Abstract][Full Text] [Related]
10. Monocarboxylate transporter 1 and 4 inhibitors as potential therapeutics for treating solid tumours: A review with structure-activity relationship insights.
Puri S; Juvale K
Eur J Med Chem; 2020 Aug; 199():112393. PubMed ID: 32388280
[TBL] [Abstract][Full Text] [Related]
11. Novel N,N-dialkyl cyanocinnamic acids as monocarboxylate transporter 1 and 4 inhibitors.
Jonnalagadda S; Jonnalagadda SK; Ronayne CT; Nelson GL; Solano LN; Rumbley J; Holy J; Mereddy VR; Drewes LR
Oncotarget; 2019 Mar; 10(24):2355-2368. PubMed ID: 31040927
[TBL] [Abstract][Full Text] [Related]
12. Targeting metabolic activity in high-risk neuroblastoma through Monocarboxylate Transporter 1 (MCT1) inhibition.
Khan A; Valli E; Lam H; Scott DA; Murray J; Hanssen KM; Eden G; Gamble LD; Pandher R; Flemming CL; Allan S; Osterman AL; Haber M; Norris MD; Fletcher JI; Yu DMT
Oncogene; 2020 Apr; 39(17):3555-3570. PubMed ID: 32123312
[TBL] [Abstract][Full Text] [Related]
13. Glucose-dependent growth arrest of leukemia cells by MCT1 inhibition: Feeding Warburg's sweet tooth and blocking acid export as an anticancer strategy.
Pivovarova AI; MacGregor GG
Biomed Pharmacother; 2018 Feb; 98():173-179. PubMed ID: 29253765
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of MCT1 inhibits tumor growth, metastasis and enhances chemotherapeutic efficacy in osteosarcoma through regulation of the NF-κB pathway.
Zhao Z; Wu MS; Zou C; Tang Q; Lu J; Liu D; Wu Y; Yin J; Xie X; Shen J; Kang T; Wang J
Cancer Lett; 2014 Jan; 342(1):150-8. PubMed ID: 24012639
[TBL] [Abstract][Full Text] [Related]
15. Preclinical Efficacy of the Novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of Resistance.
Quanz M; Bender E; Kopitz C; Grünewald S; Schlicker A; Schwede W; Eheim A; Toschi L; Neuhaus R; Richter C; Toedling J; Merz C; Lesche R; Kamburov A; Siebeneicher H; Bauser M; Hägebarth A
Mol Cancer Ther; 2018 Nov; 17(11):2285-2296. PubMed ID: 30115664
[TBL] [Abstract][Full Text] [Related]
16. Cellular Uptake of MCT1 Inhibitors AR-C155858 and AZD3965 and Their Effects on MCT-Mediated Transport of L-Lactate in Murine 4T1 Breast Tumor Cancer Cells.
Guan X; Rodriguez-Cruz V; Morris ME
AAPS J; 2019 Jan; 21(2):13. PubMed ID: 30617815
[TBL] [Abstract][Full Text] [Related]
17. Novel strategies to improve tumour therapy by targeting the proteins MCT1, MCT4 and LAT1.
Wang Y; Qin L; Chen W; Chen Q; Sun J; Wang G
Eur J Med Chem; 2021 Dec; 226():113806. PubMed ID: 34517305
[TBL] [Abstract][Full Text] [Related]
18. Human estrogen receptor α antagonists, part 2: Synthesis driven by rational design, in vitro antiproliferative, and in vivo anticancer evaluation of innovative coumarin-related antiestrogens as breast cancer suppressants.
Kurtanović N; Tomašević N; Matić S; Mitrović MM; Kostić DA; Sabatino M; Antonini L; Ragno R; Mladenović M
Eur J Med Chem; 2022 Jan; 227():113869. PubMed ID: 34710747
[TBL] [Abstract][Full Text] [Related]
19. MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis.
Lee JY; Lee I; Chang WJ; Ahn SM; Lim SH; Kim HS; Yoo KH; Jung KS; Song HN; Cho JH; Kim SY; Kim KM; Lee S; Kim ST; Park SH; Lee J; Park JO; Park YS; Lim HY; Kang WK
Oncotarget; 2016 Jul; 7(28):43492-43503. PubMed ID: 27224918
[TBL] [Abstract][Full Text] [Related]
20. Functional activity of a monocarboxylate transporter, MCT1, in the human retinal pigmented epithelium cell line, ARPE-19.
Majumdar S; Gunda S; Pal D; Mitra AK
Mol Pharm; 2005; 2(2):109-17. PubMed ID: 15804185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
